New direct-acting antiviral medications are more effective than previous treatments, as they are short in duration, easy to take, have few side effects and cure more than 90 percent of the people taking them, according to WHO. “This is a vast improvement from older treatments, which cured less than half of the people treated, required weekly interferon injections for up to 12 months, and often resulted in severe, sometimes fatal, side effects,” according to WHO.
Even though these new drugs are highly effective, their price vary dramatically in different countries, so WHO recognizes that implementation of the new guidelines may not be immediate.
More articles on hepatitis C:
US payments on prescription drugs rose 12.2% in 2015: 7 things to know
Researchers say current hep C testing guidelines overlook many cases
Experts say eliminating hepatitis B and C as US public health concern is possible
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
